Programmed Cell Death Protein 1 (PD-1/PD-1L) expression is the best documented immunosuppressive mechanism in meningiomas [77,86,87] but has only been evaluated in the treatment of other brain tumours rather than meningiomas [88]. Here, PDCD1 is linked to meningioma.